Order Article Reprints

Calò F, Onorato L, Pisaturo M, Pinto A, Alessio L, Monari C, Minichini C, Arcamone M, Di Fraia A, Atripaldi L, et al. Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. Vaccines. 2022; 10(7):1021. https://doi.org/10.3390/vaccines10071021

Calò, Federica, Lorenzo Onorato, Mariantonietta Pisaturo, Antonio Pinto, Loredana Alessio, Caterina Monari, Carmine Minichini, Manuela Arcamone, Alessandra Di Fraia, Luigi Atripaldi, and et al. 2022. "Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report" Vaccines 10, no. 7: 1021. https://doi.org/10.3390/vaccines10071021

Calò, F., Onorato, L., Pisaturo, M., Pinto, A., Alessio, L., Monari, C., Minichini, C., Arcamone, M., Di Fraia, A., Atripaldi, L., Tiberio, C., & Coppola, N. (2022). Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. Vaccines, 10(7), 1021. https://doi.org/10.3390/vaccines10071021